These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25000562)
21. Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β. Galea GL; Meakin LB; Sugiyama T; Zebda N; Sunters A; Taipaleenmaki H; Stein GS; van Wijnen AJ; Lanyon LE; Price JS J Biol Chem; 2013 Mar; 288(13):9035-48. PubMed ID: 23362266 [TBL] [Abstract][Full Text] [Related]
22. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Zeng Q; Chen GG; Vlantis AC; van Hasselt CA Cell Prolif; 2007 Dec; 40(6):921-35. PubMed ID: 18021179 [TBL] [Abstract][Full Text] [Related]
23. Distinct roles of estrogen receptors alpha and beta mediating acute vasodilation of epicardial coronary arteries. Traupe T; Stettler CD; Li H; Haas E; Bhattacharya I; Minotti R; Barton M Hypertension; 2007 Jun; 49(6):1364-70. PubMed ID: 17470727 [TBL] [Abstract][Full Text] [Related]
24. Estrogen and soy isoflavonoids decrease sensitivity of medulloblastoma and central nervous system primitive neuroectodermal tumor cells to chemotherapeutic cytotoxicity. Belcher SM; Burton CC; Cookman CJ; Kirby M; Miranda GL; Saeed FO; Wray KE BMC Pharmacol Toxicol; 2017 Sep; 18(1):63. PubMed ID: 28877739 [TBL] [Abstract][Full Text] [Related]
25. Studies on estrogen receptor (ER) alpha and beta responses on gene regulation in peripheral blood leukocytes in vivo using selective ER agonists. Stygar D; Masironi B; Eriksson H; Sahlin L J Endocrinol; 2007 Jul; 194(1):101-19. PubMed ID: 17592025 [TBL] [Abstract][Full Text] [Related]
26. Estrogen receptor-α but not -β or GPER inhibits high glucose-induced human VSMC proliferation: potential role of ROS and ERK. Ortmann J; Veit M; Zingg S; Di Santo S; Traupe T; Yang Z; Völzmann J; Dubey RK; Christen S; Baumgartner I J Clin Endocrinol Metab; 2011 Jan; 96(1):220-8. PubMed ID: 20962025 [TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor agonists and estrogen attenuate TNF-α-induced apoptosis in VSC4.1 motoneurons. Das A; Smith JA; Gibson C; Varma AK; Ray SK; Banik NL J Endocrinol; 2011 Feb; 208(2):171-82. PubMed ID: 21068071 [TBL] [Abstract][Full Text] [Related]
30. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Helguero LA; Faulds MH; Gustafsson JA; Haldosén LA Oncogene; 2005 Oct; 24(44):6605-16. PubMed ID: 16007178 [TBL] [Abstract][Full Text] [Related]
31. Effect of oestrogen receptor alpha and beta agonists on brain N-methyl-D-aspartate receptors. Morissette M; Le Saux M; Di Paolo T J Neuroendocrinol; 2008 Aug; 20(8):1006-14. PubMed ID: 18510708 [TBL] [Abstract][Full Text] [Related]
33. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med. Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332 [TBL] [Abstract][Full Text] [Related]
34. 17β-Estradiol upregulates ecto-5'-nucleotidase (CD73) in hippocampal synaptosomes of female rats through action mediated by estrogen receptor-α and -β. Mitrović N; Zarić M; Drakulić D; Martinović J; Stanojlović M; Sévigny J; Horvat A; Nedeljković N; Grković I Neuroscience; 2016 Jun; 324():286-96. PubMed ID: 26987957 [TBL] [Abstract][Full Text] [Related]
35. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer. Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599 [TBL] [Abstract][Full Text] [Related]
36. Protective role of 17 β-estradiol on medulloblastoma development in Patched 1 heterozygous mice. Mancuso M; Leonardi S; Ceccarelli M; Pasquali E; De Stefano I; Prisco MG; Rebessi S; Tanori M; Scambia G; Di Majo V; Pazzaglia S; Saran A; Gallo D Int J Cancer; 2010 Dec; 127(12):2749-57. PubMed ID: 21351254 [TBL] [Abstract][Full Text] [Related]
37. Growth and Bone Mineral Density Changes in Ovariectomized Rats Treated with Estrogen Receptor Alpha or Beta Agonists. Kang BH; Cho JH; Kim SY; Jeong KA; Kim SH; Kim C; Lim SJ; Shim KS J Korean Med Sci; 2020 Nov; 35(45):e370. PubMed ID: 33230983 [TBL] [Abstract][Full Text] [Related]
38. Effects of estrogen receptor α and β on the expression of visfatin and retinol-binding protein 4 in 3T3-L1 adipocytes. Jung US; Jeong KJ; Kang JK; Yi K; Shin JH; Seo HS; Kim T; Kim SH; Hur JY Int J Mol Med; 2013 Sep; 32(3):723-8. PubMed ID: 23857051 [TBL] [Abstract][Full Text] [Related]
39. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β. Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400 [TBL] [Abstract][Full Text] [Related]
40. Effects of selective estrogen receptor alpha and beta modulators on prepulse inhibition in male mice. Labouesse MA; Langhans W; Meyer U Psychopharmacology (Berl); 2015 Aug; 232(16):2981-94. PubMed ID: 25893642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]